Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Hai-Mei Yang"'
Publikováno v:
Journal of Nutritional Oncology. 5:182-188
Objective There is strong evidence that the body composition can affect the progression-free survival (PFS) and overall survival (OS) in patients with a variety of cancers. The main objective of this study was to investigate the effect of body compos
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::559d58951d640e0fabc6b99e8e09e871
https://doi.org/10.34175/jno202004005
https://doi.org/10.34175/jno202004005
Autor:
Li-Li Zhang, Juan Deng, Bin Lu Sun, Liang Tan, Jun Wang, Hai Mei Yang, Noralyn B. Mañucat-Tan, Ye Ran Wang, Zhong Yuan Yu, Zi Cheng Hu, Yu Hui Liu, Wei Wei Li
Hyperphosphorylated tau is an important pathological agent in Alzheimer’s disease (AD). Tau effluxes from the brain to the blood could potentially stimulate the production of naturally occurring antibodies (NAbs). We aimed to investigate whether NA
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d25b2004f5d03b15ae0623d9dcc2805c
https://hdl.handle.net/11541.2/141232
https://hdl.handle.net/11541.2/141232
Autor:
Lun-Xi Li, Da-Yan Wang, Tong Yang, Hai-Mei Yang, Chun-hua Tang, Lu Guo, Qiong Li, Jie Zhu, Li-Li Zhang
Publikováno v:
Neuroscience letters. 729
Hyperthyroidism may cause cognitive decline and increases the risk of Alzheimer's disease (AD), the major form of dementia; however, the underlying mechanism of this relationship is unclear. AD is associated with increased serum levels of tau. In thi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5aa4b404b27f546f3c42a3d7a686638a
https://pubmed.ncbi.nlm.nih.gov/32335219
https://pubmed.ncbi.nlm.nih.gov/32335219
Autor:
Yuan-Biao, Qiao, Lan-Fang, Zhang, Qi, Qiao, Jia-Hui, Niu, Ze-Mei, Ren, Hai-Mei, Yang, Chen-Chen, Zhu, Hong-Ju, Pan, Nan-Nan, Duan, Qing-Shan, Li
Publikováno v:
Medical Mycology; Jun2021, Vol. 59 Issue 6, p515-527, 13p
Autor:
Yuan-Biao Q; Shanxi Key Laboratory of Innovative Drugs for the Treatment of Serious Diseases Basing on Chronic Inflammation, College of Traditional Chinese Medicines, Shanxi University of Chinese Medicine, Taiyuan, Shanxi 030619, P. R. China.; Graduate Institute of Pharmaceutical Chemistry, Luliang University, Luliang, Shanxi 033001, P. R. China., Lan-Fang Z; Shanxi Key Laboratory of Innovative Drugs for the Treatment of Serious Diseases Basing on Chronic Inflammation, College of Traditional Chinese Medicines, Shanxi University of Chinese Medicine, Taiyuan, Shanxi 030619, P. R. China., Qi Q; Department of Medical Biochemistry and Microbiology, Uppsala Biomedical Center, Uppsala University, Husargatan 3, Box 582, SE-751 23 Uppsala, Sweden., Jia-Hui N; Graduate Institute of Pharmaceutical Chemistry, Luliang University, Luliang, Shanxi 033001, P. R. China., Ze-Mei R; Graduate Institute of Pharmaceutical Chemistry, Luliang University, Luliang, Shanxi 033001, P. R. China., Hai-Mei Y; Graduate Institute of Pharmaceutical Chemistry, Luliang University, Luliang, Shanxi 033001, P. R. China., Chen-Chen Z; Graduate Institute of Pharmaceutical Chemistry, Luliang University, Luliang, Shanxi 033001, P. R. China., Hong-Ju P; Graduate Institute of Pharmaceutical Chemistry, Luliang University, Luliang, Shanxi 033001, P. R. China., Nan-Nan D; Graduate Institute of Pharmaceutical Chemistry, Luliang University, Luliang, Shanxi 033001, P. R. China., Qing-Shan L; Shanxi Key Laboratory of Innovative Drugs for the Treatment of Serious Diseases Basing on Chronic Inflammation, College of Traditional Chinese Medicines, Shanxi University of Chinese Medicine, Taiyuan, Shanxi 030619, P. R. China.
Publikováno v:
Medical mycology [Med Mycol] 2020 Sep 01. Date of Electronic Publication: 2020 Sep 01.